Researchers tested a traditional Chinese herbal formula called Er-Chen Decoction on mice with fatty liver disease caused by eating too much fatty food. The formula worked about as well as a modern diabetes medicine at reducing liver fat, improving insulin resistance, and lowering unhealthy cholesterol. The key was that the herbal formula changed the helpful bacteria in the gut, which then produced special compounds that strengthened the intestinal barrier and reduced harmful inflammation in the liver. This study suggests that this ancient remedy might offer a new way to treat fatty liver disease by working through the gut-liver connection.

The Quick Take

  • What they studied: Whether a traditional Chinese herbal formula (Er-Chen Decoction) could treat fatty liver disease by changing gut bacteria and improving the connection between the gut and liver
  • Who participated: Mice fed a high-fat diet to develop fatty liver disease similar to what happens in humans with metabolic problems
  • Key finding: The herbal formula reduced liver fat and improved metabolic problems about as effectively as semaglutide, a modern prescription medicine, but it worked through a different mechanism by boosting beneficial bacteria that produce protective compounds
  • What it means for you: This research suggests that traditional herbal remedies may offer a promising alternative approach to treating fatty liver disease, though human studies are needed before it can be recommended as a treatment. The findings are encouraging but not yet proven in people.

The Research Details

Scientists created fatty liver disease in mice by feeding them a high-fat diet, similar to how humans develop this condition. They then treated some mice with Er-Chen Decoction (a traditional Chinese herbal formula) and compared the results to mice treated with semaglutide (a modern medicine) and untreated mice. The researchers used advanced laboratory techniques to examine what happened at multiple levels: they looked at the bacteria in the mice’s intestines, measured chemical changes in the blood, analyzed gene activity in the liver, and studied the molecular pathways involved in the healing process. This multi-layered approach allowed them to understand not just whether the treatment worked, but exactly how it worked.

This research approach is important because it goes beyond simply showing that a treatment works—it reveals the specific biological mechanisms. Understanding how Er-Chen Decoction affects the gut bacteria, which then influences the intestinal barrier and ultimately the liver, provides a scientific explanation for why this traditional medicine might be effective. This kind of detailed mechanism research helps validate traditional remedies and could lead to better treatments.

The study used sophisticated modern laboratory techniques including genetic sequencing of gut bacteria, advanced chemical analysis of blood compounds, and gene expression analysis in liver tissue. These methods provide reliable, objective measurements. However, this research was conducted only in mice, not humans, so results may not directly translate to people. The study was published in a peer-reviewed scientific journal, which means other experts reviewed it for quality. The lack of a specified sample size in the abstract makes it harder to assess statistical power, though mouse studies typically use adequate numbers for reliable results.

What the Results Show

The herbal formula significantly reduced the amount of fat stored in the liver, improved how well the body used insulin (insulin resistance), and lowered unhealthy cholesterol levels. These improvements were comparable to those seen with semaglutide, a well-established modern medicine for metabolic problems. However, the herbal formula achieved these results through a completely different biological pathway. While semaglutide primarily increased a specific beneficial bacterium called Akkermansia, the herbal formula instead boosted two different beneficial bacteria: Bifidobacterium and Lactobacillus. These bacteria produced special compounds called indoles (specifically indoleacrylic acid and indole-3-acetic acid) that appeared to be the key to the treatment’s effectiveness.

The indole compounds produced by the beneficial bacteria activated a cellular receptor called the aryl hydrocarbon receptor (AHR) in the colon. This activation strengthened the intestinal barrier by increasing protective proteins called tight junction proteins (ZO-1 and Occludin). A stronger intestinal barrier prevented harmful bacterial toxins (lipopolysaccharides) from leaking into the bloodstream. In the liver, reduced toxin exposure allowed a protein called DNMT3B to function properly, which then turned off genes responsible for storing excess fat. This epigenetic mechanism—essentially silencing fat-storage genes without changing the genes themselves—appears to be how the herbal formula reverses liver damage.

Previous research has shown that gut bacteria play an important role in fatty liver disease, and that the gut-liver connection is disrupted in this condition. This study builds on that knowledge by identifying a specific herbal formula that can restore this connection. Unlike semaglutide, which works primarily through hormone signaling, Er-Chen Decoction works by modifying the bacterial community itself. This represents a different therapeutic strategy that may appeal to people seeking alternatives to pharmaceutical approaches, though both methods appear effective in this mouse model.

The most significant limitation is that this research was conducted only in mice, not humans. Mice metabolize substances differently than people, and results in animals don’t always translate to humans. The study doesn’t specify the exact number of mice used, making it difficult to assess whether the sample size was adequate. The research also doesn’t address potential side effects or safety concerns in humans. Additionally, while the study identifies the biological mechanisms, it doesn’t determine the optimal dose or duration of treatment, nor does it compare Er-Chen Decoction to other traditional remedies. Finally, the study was conducted in a controlled laboratory setting, which differs from real-world conditions where diet, lifestyle, and other factors vary.

The Bottom Line

Based on this research, Er-Chen Decoction shows promise as a potential treatment for fatty liver disease and may work through beneficial changes to gut bacteria. However, these findings are preliminary and based on mouse studies only. Current recommendation level: Promising research, but not yet ready for clinical use without human studies. Anyone with fatty liver disease should continue working with their healthcare provider on proven treatments (weight loss, exercise, dietary changes) while this research progresses toward human trials.

This research is most relevant to people with metabolic dysfunction-associated fatty liver disease (MASLD), particularly those interested in traditional medicine approaches or those who don’t tolerate modern medications well. Researchers studying gut health, liver disease, and traditional medicine should also pay attention to these findings. People without fatty liver disease don’t need to act on this information yet. Those with liver disease should not self-treat with herbal formulas without medical supervision.

In the mouse studies, improvements in liver fat and metabolic markers were observed over the treatment period, though the exact timeline isn’t specified in the abstract. If this research progresses to human trials, it typically takes 2-5 years to complete Phase 1 and Phase 2 studies, and several more years for Phase 3 trials. Realistic expectation: 5-10 years before this could potentially become an approved treatment for humans, assuming positive human trial results.

Want to Apply This Research?

  • Users interested in gut health could track daily intake of foods that promote beneficial bacteria (fiber, fermented foods) and monitor digestive symptoms weekly using a simple 1-10 scale. This creates a baseline for understanding personal gut health patterns.
  • Users could set a goal to increase consumption of prebiotic foods (foods that feed beneficial bacteria like Bifidobacterium and Lactobacillus) such as garlic, onions, bananas, and oats. The app could provide daily reminders and track compliance with this dietary change.
  • Implement a long-term tracking system that monitors weekly digestive health scores, dietary fiber intake, and fermented food consumption. Users could also log any changes in energy levels or digestive comfort. This data could be reviewed monthly to identify patterns and adjust dietary strategies accordingly.

This research was conducted in mice and has not been tested in humans. Er-Chen Decoction should not be used as a treatment for fatty liver disease without consulting a healthcare provider. The findings are preliminary and require human clinical trials before any medical recommendations can be made. People with liver disease should work with their doctor on proven treatments including weight loss, exercise, and dietary modifications. This summary is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any new treatment, including herbal remedies.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Er-Chen Decoction ameliorates metabolic dysfunction-associated steatotic liver disease via gut microbiota-barrier axis-driven hepatic metabolic reprogramming.Frontiers in microbiology (2026). PubMed 41918527 | DOI